Some recent M&A deals FYI. Lots of activity in the cancer space. Apologies for editing. HC not that user friendly
COMPANY ACQUIRED DATE OF DEAL TOTAL CONSIDERATION PRICE PER SHARE PREMIUM
Johnson & Ambrx Biopharma 1/8/24 $2,000M $28.00 105%
Johnson
Merck & Co. Harpoon Therapeutics c1/8/24 $680M $23.00 118%
AstraZeneca Gracell 12/26/23 $1,000M $2.00 62%
Bristol Myers RayzeBio 12/26/23 $4,100M $62.50 104%
Squibb
Bristol Myers Karuna Therapeutics 12/22/23 $14,000M $330.00 53%
Squibb
AbbVie Cerevel Therapeutics 12/6/23 $8,700M $45.00 22%
AbbVie ImmunoGen 11/30/23 $10,100M $31.26 95%
Eli Lilly Point Biopharma 10/3/23 $1,400M $12.50 87%
Some recent M&A deals FYI. Lots of activity in the cancer space....
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.02 |
Change
-1.250(6.17%) |
Mkt cap ! $2.428B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $18.82 | $19.92M | 1.034M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1652 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.03 | 11612 | 4 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.10 |
Change
-1.250 ( 6.19 %) |
||||
| Open | High | Low | Volume | ||
| $20.39 | $20.46 | $18.83 | 299764 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| NEU (ASX) Chart |